These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3090427)

  • 1. Genetic polymorphisms and atherosclerosis.
    Galton DJ
    Monogr Atheroscler; 1986; 14():113-8. PubMed ID: 3090427
    [No Abstract]   [Full Text] [Related]  

  • 2. [DNA restriction fragment length polymorphism (RFLP) of insulin and apolipoprotein A-I (apo A-I) genes in patients with diabetes mellitus coexistent with polyendocrinopathy].
    Grzywa M; Buraczyńska M; Tatoń J; Matwiszyn B
    Pol Tyg Lek; 1987 Dec; 42(50):1598-601. PubMed ID: 2898774
    [No Abstract]   [Full Text] [Related]  

  • 3. Apolipoprotein genes, DNA polymorphisms and hyperlipidemia.
    Shoulders CC; Baralle FE
    Agents Actions Suppl; 1984; 16():17-33. PubMed ID: 6091427
    [No Abstract]   [Full Text] [Related]  

  • 4. DNA polymorphisms as potential genetic risk markers for cardiovascular diseases.
    Cocozza S; Monticelli A; Garofalo S; Riccardi G; Cortese R; Quirico N; Ricci A; Cicerone R; Rossi F; Varrone S
    Boll Soc Ital Biol Sper; 1987 Sep; 63(9):771-7. PubMed ID: 2896009
    [No Abstract]   [Full Text] [Related]  

  • 5. PCR methodology applied to genetic studies of lipoprotein metabolism and atherosclerosis.
    Cole SA; Hixson JE
    Methods Mol Biol; 1998; 110():1-34. PubMed ID: 9918036
    [No Abstract]   [Full Text] [Related]  

  • 6. No association of apolipoprotein A-IV codon 347 and 360 variation with atherosclerosis and lipid transport in a sample of mixed hyperlipidemics.
    Carrejo MH; Sharrett R; Patsch W; Boerwinkle E
    Genet Epidemiol; 1995; 12(4):371-80. PubMed ID: 8536954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular genetics of hyperlipidemia.
    Shoulders CC; Baralle FE
    Horiz Biochem Biophys; 1986; 8():299-340. PubMed ID: 2875933
    [No Abstract]   [Full Text] [Related]  

  • 8. [Polymorphism of the apolipoprotein A-I gene and susceptibility to non-insulin-dependent diabetes mellitus].
    Buraczyńska M; Hanzlik J; Grzywa M
    Pol Tyg Lek; 1987 Dec; 42(50):1602-5. PubMed ID: 3452804
    [No Abstract]   [Full Text] [Related]  

  • 9. DNA, hyperlipidaemias and atherosclerosis.
    Kontula K; Aalto-Setälä K; Nikkilä E
    Ann Clin Res; 1986; 18(5-6):242-9. PubMed ID: 3551772
    [No Abstract]   [Full Text] [Related]  

  • 10. The genetics of atherosclerosis.
    Galton DJ
    Proc Nutr Soc; 1987 Sep; 46(3):337-43. PubMed ID: 3124116
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic research in coronary heart disease.
    Motulsky AG
    Prog Clin Biol Res; 1984; 147():541-8. PubMed ID: 6330756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout.
    Cardona F; Tinahones FJ; Collantes E; Escudero A; García-Fuentes E; Soriguer FJ
    Ann Rheum Dis; 2005 Jan; 64(1):85-8. PubMed ID: 15115711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of coronary heart disease and its risk factors.
    Berg K
    Prog Clin Biol Res; 1985; 177():351-74. PubMed ID: 3160046
    [No Abstract]   [Full Text] [Related]  

  • 14. [Epidemiology and molecular genetics of atherosclerosis].
    Cambien F
    Journ Annu Diabetol Hotel Dieu; 1991; ():19-24. PubMed ID: 1679467
    [No Abstract]   [Full Text] [Related]  

  • 15. DNA polymorphisms flanking the apo A-1 and insulin genes and type III hyperlipidaemia.
    Vella M; Kessling A; Jowett N; Rees A; Stocks J; Wallis S; Galton D
    Hum Genet; 1985; 69(3):275-6. PubMed ID: 2984107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between primary gout and hypertriglyceridaemia may be due to genetic linkage.
    Ferns GA; Lanham J; Galton DJ
    Monogr Atheroscler; 1985; 13():121-3. PubMed ID: 3937047
    [No Abstract]   [Full Text] [Related]  

  • 17. [Polymorphism of the DNA restriction fragment length flanking the insulin gene. A genetic marker for diabetic mellitus or atherosclerosis?].
    Mandrup-Poulsen T; Owerbach D; Johansen K; Nerup J
    Ugeskr Laeger; 1985 Jun; 147(26):2065-71. PubMed ID: 2996193
    [No Abstract]   [Full Text] [Related]  

  • 18. The genetics of the hyperlipidemias and coronary artery disease.
    Berg K
    Prog Clin Biol Res; 1982; 103 Pt B():111-25. PubMed ID: 7163216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA polymorphisms of the apolipoprotein genes--their use in the investigation of the genetic component of hyperlipidaemia and atherosclerosis.
    Humphries SE
    Atherosclerosis; 1988 Aug; 72(2-3):89-108. PubMed ID: 3063270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetics and dyslipidemias].
    Brousseau T; Fruchart JCh
    Arch Mal Coeur Vaiss; 2003 Nov; 96(11):1116-20. PubMed ID: 14694789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.